Denali Therapeutics Inc. (DNLI) Operating Lease, Liability USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Denali Therapeutics Inc. quarterly Operating Lease, Liability history and growth rate from 2019 to 2024.
  • Denali Therapeutics Inc. Operating Lease, Liability for the quarter ending March 31, 2024 was $50.5 M, a 11.5% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $50.5 M -$6.54 M -11.5% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $52.2 M -$8.11 M -13.4% Dec 31, 2023 10-K 2024-02-28
Q3 2023 $53.9 M -$8.15 M -13.1% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $55.5 M -$5.87 M -9.56% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $57.1 M -$5.66 M -9.02% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $60.4 M -$3.66 M -5.71% Dec 31, 2022 10-K 2023-02-27
Q3 2022 $62 M -$3.2 M -4.9% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $61.4 M -$5.06 M -7.61% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $62.7 M -$5.05 M -7.45% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $64 M -$4.86 M -7.05% Dec 31, 2021 10-K 2022-02-28
Q3 2021 $65.2 M -$4.67 M -6.68% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $66.5 M -$4.49 M -6.33% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $67.8 M -$4.12 M -5.73% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $68.9 M -$3.67 M -5.05% Dec 31, 2020 10-K 2021-02-26
Q3 2020 $69.9 M -$3.25 M -4.45% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $70.9 M -$1.93 M -2.65% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $71.9 M -$248 K -0.34% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $72.5 M Dec 31, 2019 10-K 2020-02-27
Q3 2019 $73.2 M Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $72.9 M Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $72.2 M Mar 31, 2019 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.